Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model. - Wikidata - wikimedia - TriplyDB

Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.

Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.

http://www.wikidata.org/entity/Q34922452

about

Investigational drugs to treat methicillin-resistant Staphylococcus aureus The role of genetics and antibodies in sepsis Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice.Virulence determinants associated with the Asian community-associated methicillin-resistant Staphylococcus aureus lineage ST59.Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.Prevention and treatment of Staphylococcus aureus biofilms.EssE Promotes Staphylococcus aureus ESS-Dependent Protein Secretion To Modify Host Immune Responses during Infection.A new approach to toxin neutralization in Staphylococcus aureus therapy.The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.α-Toxin Regulates Local Granulocyte Expansion from Hematopoietic Stem and Progenitor Cells in Staphylococcus aureus-Infected Wounds.New horizons in hospital acquired pneumonia in older people.Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.CP and CP-PGN protect mice against MRSA infection by inducing M1 macrophages.Broad-Spectrum Neutralization of Pore-Forming Toxins with Human Erythrocyte Membrane-Coated Nanosponges.MEDI3902 correlates of protection against severe Pseudomonas aeruginosa pneumonia in a rabbit acute pneumonia model.Alpha-Toxin Contributes to Biofilm Formation among Staphylococcus aureus Wound Isolates.Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development.

P2860

Q26780246-157115FD-3CF5-4B4A-80FD-E15973C9D908 Q28075279-6A5AAC5E-C718-4999-983F-ABE0FD61B835 Q35439724-D8FED6DA-4212-4828-9204-E89A5AC433E8 Q35859999-6F0924FA-CACA-421B-853F-8C13B7EC6040 Q35939497-9BA082AF-69BB-487A-A037-77C367062738 Q37000378-59E1DAD6-44C9-4FF4-B16C-5AD87E8680BB Q37287845-03122E96-0C3B-489D-B330-8C0A98426BD5 Q37482155-771F418A-009B-493A-90D2-9F46937CF80B Q37512427-F8EE3055-733D-48E3-BFC2-746C792AC2A6 Q38699896-3796AC8B-6F0D-4CB2-BD9B-E6FFFB7B4BB7 Q38805996-F874B77D-57B2-46A0-BFF9-5F156C1313F9 Q40124323-C01AF223-7290-443C-A5EC-1CBB541B8613 Q40279983-2B2ECC99-B016-45B3-80B6-448F3AE2AED3 Q40416064-4389D54E-BA63-4C89-8266-B135462BC588 Q47136179-59A15A89-5AE2-4F6E-9997-6CF9E9722413 Q50049653-3B075028-518C-4005-A50A-10B80CBF9EEA Q51747341-18C717FD-78EE-4F12-ACC3-70ED655B1581 Q55043754-7E43411B-B71F-465A-A962-904BB126C6C7 Q55246404-8E3B7753-1DD2-4CC5-A8EF-6F2B727045AF

P2860

Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.

http://www.wikidata.org/entity/Q34922452

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Anti-alpha-toxin monoclonal an ...... us aureus dermonecrosis model.

@ast

Anti-alpha-toxin monoclonal an ...... us aureus dermonecrosis model.

@en

Anti-alpha-toxin monoclonal an ...... us aureus dermonecrosis model.

@nl

type

label

Anti-alpha-toxin monoclonal an ...... us aureus dermonecrosis model.

@ast

Anti-alpha-toxin monoclonal an ...... us aureus dermonecrosis model.

@en

Anti-alpha-toxin monoclonal an ...... us aureus dermonecrosis model.

@nl

prefLabel

Anti-alpha-toxin monoclonal an ...... us aureus dermonecrosis model.

@ast

Anti-alpha-toxin monoclonal an ...... us aureus dermonecrosis model.

@en

Anti-alpha-toxin monoclonal an ...... us aureus dermonecrosis model.

@nl

P1433

Q34922452-5A1F1F3E-E650-497D-9FE4-53A40CD9385D

P1476

Q34922452-C624D61B-C8A6-461E-A5F4-D22BA517F6D4

P2093

Q34922452-043C1835-CBAD-47C2-997F-F66E357938C1

Q34922452-2A381E84-F615-43D7-8DB0-4BF55FD58576

Q34922452-4F6F2B30-1CFD-4FCE-80BF-7FBC15C89AA5

Q34922452-7E22C82F-14A3-4E2C-999A-997545C8C1D1

Q34922452-85292F80-547E-4612-9471-EE47DC7314C3

Q34922452-97DF9BF7-84D0-4E5A-9092-D0FD52E0F51E

Q34922452-9DB9943C-6AB3-42FD-9D02-D076F46B6D0B

Q34922452-A144C7C5-A715-4329-B93B-F622D57F1D22

Q34922452-B133278A-3E14-488A-9144-F68EC18D0935

Q34922452-B2DA3FF8-1743-4F61-BB8A-CFD16C8BD4EA

P2860

Q34922452-03960187-1CCA-481B-97BA-5E637B1DFDCE

Q34922452-04B03EEB-6908-4F5D-8AB3-FAD2CEF9F122

Q34922452-144A95E7-4586-4074-B81F-F187786BF36B

Q34922452-1719CCC5-B425-4770-AEDE-76A8EA445471

Q34922452-1D3D4F12-C3FA-4B6E-A215-36D2122CAD5A

Q34922452-22821A12-03DE-417A-B8D9-9D9C385A0AEF

Q34922452-276247DE-FBF8-46D6-A775-FC39CA3B86FA

Q34922452-2A1E2283-380E-4F38-8AA4-14DA9BA17BFF

Q34922452-31DFFBD3-0D93-4575-B46B-08239B97D075

Q34922452-35CE2BCD-F6FD-4A61-8FF0-7EBBBEDE0F21

P304

Q34922452-8A283CC7-CD85-4E5E-BC2D-9D054E32E437

P31

Q34922452-82114385-5964-4ECD-B41B-C5AD550903A1

P356

Q34922452-F1600347-0750-45E5-AADA-0F6B18EC1EAC

P407

Q34922452-2B6EBDD6-0C34-4AFC-AD6B-B3056FD87CE2

P433

Q34922452-E5080A03-F7E2-46A6-B5C5-9F337462B040

P478

Q34922452-A7F35A34-9573-4724-9CA9-46CC57E7E20E

P50

Q34922452-3D38D338-BDAF-461A-A84D-4BDB08290CC3

P577

Q34922452-B73CA504-2FCD-4505-A5DC-F734ED60227B

P698

Q34922452-AD02D711-83E5-4562-B923-DF4AE8086F9E

P921

Q34922452-AE595B31-1AB7-4E16-978F-3945E53C6DE1

P932

Q34922452-26661ECA-7468-487D-A537-BC23A55434AB

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Anti-alpha-toxin monoclonal an ...... cus aureus dermonecrosis model

@en

P2093

Agnieszka Sadowska

http://www.w3.org/2001/XMLSchema#string

Bret R Sellman

http://www.w3.org/2001/XMLSchema#string

C Kendall Stover

http://www.w3.org/2001/XMLSchema#string

Christine Tkaczyk

http://www.w3.org/2001/XMLSchema#string

Jamese J Hilliard

http://www.w3.org/2001/XMLSchema#string

JoAnn Suzich

http://www.w3.org/2001/XMLSchema#string

Melissa Hamilton

http://www.w3.org/2001/XMLSchema#string

Omari Jones-Nelson

http://www.w3.org/2001/XMLSchema#string

Szabolcs Szarka

http://www.w3.org/2001/XMLSchema#string

Terrence O'Day

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccine protection against Staphylococcus aureus pneumonia

Staphylococcus aureus α-toxin: nearly a century of intrigue

Resistance to linezolid caused by modifications at its binding site on the ribosome

Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study

Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection

Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences.

IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice

Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function

Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections.

P304

299-309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.03918-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25348518

http://www.w3.org/2001/XMLSchema#string

P921

P932

4291365

http://www.w3.org/2001/XMLSchema#string